
Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February
Medical technology firm secures U.S. patent for PromarkerEso diagnostic test
for early diagnosis of esophageal cancer
Stock is down 28.8% YTD, including the session's moves